Zyversa Therapeutics, Inc.盘中异动股价大跌7.77%

市场透视2025-04-14

北京时间2025年04月14日21时32分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价急速跳水7.77%。截至发稿，该股报0.710美元/股，成交量4.1342万股，换手率1.65%，振幅7.78%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-9.41百万美元，每股收益-8.48美元，毛利-6933.00美元，市盈率-0.09倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2527193579?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-14 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2527193579","market":"us","top_or_hot":-1,"title":"Zyversa Therapeutics, Inc.盘中异动 股价大跌7.77%","media":"市场透视","content":"<div>\n<p>北京时间2025年04月14日21时32分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价急速跳水7.77%。截至发稿，该股报0.710美元/股，成交量4.1342万股，换手率1.65%，振幅7.78%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-9.41百万美元，每股收益-8.48美元，毛利-6933.00美元，市盈率-0.09倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zyversa Therapeutics, Inc.盘中异动 股价大跌7.77%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZyversa Therapeutics, Inc.盘中异动 股价大跌7.77%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-14 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月14日21时32分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价急速跳水7.77%。截至发稿，该股报0.710美元/股，成交量4.1342万股，换手率1.65%，振幅7.78%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-9.41百万美元，每股收益-8.48美元，毛利-6933.00美元，市盈率-0.09倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b","article_id":"2527193579","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041421325494d50a91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2527193579","pubTimestamp":1744637573,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月14日21时32分，Zyversa Therapeutics, Inc.股票出现波动，股价急速跳水7.77%。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为276.68%、134.20%、86.80%，振幅较大的相关个股有Verrica制药、Neuraxis, Inc.、Artelo Biosciences, Inc.，振幅分别为17.60%、15.64%、13.38%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","ZVSA":"ZyVersa Therapeutics, Inc.","LENZ":"Therapeutics","BK4007":"制药"},"translate_title":"Zyversa Therapeutics, Inc. stock plunges 7.77% during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"ZVSA":0.9},"content_text":"北京时间2025年04月14日21时32分，Zyversa Therapeutics, Inc.（ZVSA.us）股票出现波动，股价急速跳水7.77%。截至发稿，该股报0.710美元/股，成交量4.1342万股，换手率1.65%，振幅7.78%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-9.41百万美元，每股收益-8.48美元，毛利-6933.00美元，市盈率-0.09倍。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Zyversa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 (To Pur Com)、Third Harmonic Bio, Inc.、Theratechnologies Inc.涨幅较大，Aditxt, Inc.、Processa Pharmaceuticals, Inc.、Soligenix, Inc.较为活跃，换手率分别为276.68%、134.20%、86.80%，振幅较大的相关个股有Verrica制药、Neuraxis, Inc.、Artelo Biosciences, Inc.，振幅分别为17.60%、15.64%、13.38%。Zyversa Therapeutics, Inc.公司简介：ZyVersa Therapeutics Inc 是一家临床阶段的生物制药公司，利用专有技术为医疗需求未得到满足的慢性肾脏或炎症性疾病患者开发药物。 该公司拥有两个专有的全球许可药物开发平台，即Cholesterol Efflux MediatorTM，VAR 200（2-羟丙基-β-环糊精）是一种处于临床开发阶段的用于治疗肾脏疾病的注射药物。 IC 100 是一种单克隆抗体炎性体 ASC 抑制剂，处于临床前开发阶段，用于治疗炎症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2527193579","isCrawlerRequest":true}

Zyversa Therapeutics, Inc.盘中异动 股价大跌7.77%

精彩评论

Zyversa Therapeutics, Inc.盘中异动股价大跌7.77%